Neurocrine Gets $10M From Venrock

12/17/09

Neurocrine Biosciences, the San Diego-based biotech company, said today it raised about $10 million through a stock offering to Venrock Associates. The company (NASDAQ: NBIX) said it sold 4.78 million shares of Neurocrine at $2.09 apiece to Venrock. That’s about an 8 percent discount to the market price of $2.27 at yesterday’s close.

By posting a comment, you agree to our terms and conditions.